Rabies Clinical Trial - Safety & Tolerability of CV8102 Alone & in

See also
Status	Clinical Trial	Phase
Completed	`NCT03961555` - Comparison of SYN023 to Human Rabies Immune Globulin in Post Exposure Prophylaxis of Rabies	Phase 2
Completed	`NCT04644484` - A Phase III Clinical Study to Evaluate SYN023's Efficacy and Safety	Phase 3
Active, not recruiting	`NCT05667974` - A Study to Evaluate a PIKA Rabies Vaccine（Vero Cell）for Human Use,Freeze-dried	Phase 3
Completed	`NCT01641315` - Immunogenicity Study of a Reduced (4-dose) Vaccine Schedule and Rabies Immunoglobulins	N/A
Completed	`NCT01930357` - Purified Vero Rabies Vaccine-Serum Free Compared to Human Diploid Cell Vaccine in a Pre-exposure Prophylaxis Regimen	Phase 2
Completed	`NCT01680016` - A Randomized, Open-label Study Comparing Two Different Rabies Vaccine Schedules in Chinese Children and Older Adults	Phase 3
Completed	`NCT04019444` - Dosage-Escalation Study of the Safety and Immunogenicity of a Novel Rabies Vaccine ChAd155-RG vs. the Comparator RABAVERT Vaccine in Healthy Adult Subjects	Phase 1
Completed	`NCT02729168` - Safety Study of Rabies Vaccine INDIRAB® Five Doses (0.5ml) Post Exposure Administered Intramuscularly	N/A
Completed	`NCT02241135` - RNActive® Rabies Vaccine (CV7201) in Healthy Adults	Phase 1
Completed	`NCT01388985` - Simplifying the Rabies Pre-exposure Vaccination	Phase 3
Completed	`NCT04829630` - Immunity Persistence After Abridged Intradermal Rabies PEP	N/A
Completed	`NCT03713086` - A Study to Assess the Safety, Reactogenicity and Immune Response of CureVac's Candidate Rabies mRNA Vaccine in Healthy Adults	Phase 1
Completed	`NCT05350735` - Phone Text Message Reminders on Compliance With Human Rabies Post Exposure Prophylaxis Project	N/A
Active, not recruiting	`NCT06132789` - A Clinical Trial of Rabies Vaccine（Human Diploid Cell）for Human Use,Freeze-dried in a Population Aged 10-60 Years	Phase 1
Completed	`NCT02281396` - The Safety Research of Freeze-dried Rabies Vaccine（MRC-5 Cell) in Chinese Humans	Phase 1
Completed	`NCT01466387` - A Phase 3b, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of Select Travel Vaccines When Administered Concomitantly With MenACWY in Adults	Phase 3
Completed	`NCT00825305` - Safety and Immunogenicity (Non-inferiority) of a Purified Chick Embryo Cell Vaccine Vaccine Administered in Two Different Schedules (Conventional Versus Abbreviated Schedule)	Phase 3
Completed	`NCT05547815` - Observation on the Immune Persistence of People Aged 10-60 Years Old Immunized With Five Doses of Rabies Vaccine	Phase 4
Completed	`NCT02564471` - Effect of Antimalarial Drugs to Rabies Vaccine for Post-exposure Prophylaxis.	Phase 4
Unknown status	`NCT01173302` - Persistence of Rabies Antibody 1-5 Years After the Post-exposure Prophylaxis With Vero Cell Antirabies Vaccine and Antibody Response to a Single Booster Dose	Phase 4

NCT number	NCT02238756
Study type	Interventional
Source	CureVac AG
Contact
Status	Completed
Phase	Phase 1
Start date	September 2014
Completion date	November 2016

Safety and Tolerability of CV8102 Alone and in Combination With a Rabies Virus Vaccine in Healthy Adults

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms